Fundraising Fox

SenesTech

NASDAQ: SNES

Phoenix, US · Founded 2015 · Delaware corporation

AgTechBiotech

Founders & leadership

TC
Thomas C. ChestermaninExecutive
JL
Joel L. FruendtinChief Executive Officer
KS
Kenneth SiegelChief Executive Officer and Director
JW
Julie Williams, MDNamed on SEC filing
MD
Marc DumontNamed on SEC filing
DF
Delphine Francois ChiavariniNamed on SEC filing

Board

MK
Matthew K. SzotBoard director
PG
Phillip Grandinetti, IIIBoard director
JL
Jake LeachBoard director
JB
Jamie Bechtel, JD, Ph.D.Board director

Reported raises · per SEC filings

Form D private placements

$17.2M disclosed across 7 of 10 rounds · 2020–2025

▶$273.5KraisedAug 2025 · 5 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Joel L. FruendtExecutive Officer, Director
  • Jake S. LeachDirector
  • Jamie Bechtel, JD, Ph.D.Director
  • Phillip N. Grandinetti, IIIDirector
  • Thomas C. ChestermanExecutive Officer
Offering amount
$273.5K
Amount sold
$273.5K
Sales commissions
$474.6K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Aug 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$182.4KraisedJul 2025 · 5 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Joel L. FruendtExecutive Officer, Director
  • Jamie Bechtel, JD, Ph.D.Director
  • Phillip N. Grandinetti, IIIDirector
  • Thomas C. ChestermanExecutive Officer
  • Jake S. LeachDirector
Offering amount
$182.4K
Amount sold
$182.4K
Sales commissions
$331K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Jun 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedMar 2025 · 5 investors · Agriculture
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas C. ChestermanExecutive Officer
  • Phillip Grandinetti, IIIDirector
  • Joel FruendtExecutive Officer
  • Jake LeachDirector
  • Jamie Bechtel, JD, Ph.D.Director
  • Matthew K. SzotDirector
  • Joshua M. MossDirector
Sales commissions
$81.5K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Mar 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedAug 2024 · 6 investors · Agriculture
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew K. SzotDirector
  • Phillip Grandinetti, IIIDirector
  • Jake LeachDirector
  • Thomas C. ChestermanExecutive Officer
  • Joel L. FruendtExecutive Officer, Director
  • Jamie Bechtel, JD, Ph.D.Director
Sales commissions
$174.4K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Aug 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedSep 2023 · 1 investors · Agriculture
Rule 506(b)
Officers, directors & promoters on the filing
  • Joel L. FruendtExecutive Officer, Director
  • Jamie Bechtel, JD, Ph.D.Director
  • Thomas C. ChestermanExecutive Officer
  • Delphine Francois ChiavariniDirector
  • Phillip Grandinetti, IIIDirector
  • Jake LeachDirector
  • Matthew K. SzotDirector
Sales commissions
$158.5K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Aug 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedApr 2023 · 4 investors · Agriculture
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew K. SzotDirector
  • Jamie Bechtel, JD, Ph.D.Director
  • Delphine Francois ChiavariniDirector
  • Thomas C. ChestermanExecutive Officer
  • Joel L. FruendtExecutive Officer, Director
  • Marc DumontDirector
  • Phil Grandinetti, IIIDirector
  • Nicole WilliamsExecutive Officer, Director
  • Jake LeachDirector
Offering amount
$1.5M
Amount sold
$1.5M
Sales commissions
$112.5K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Apr 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedFeb 2021 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jamie Bechtel, JD, Ph.D.Director
  • Delphine ChiavariniDirector
  • Marc DumontDirector
  • Matthew SzotDirector
  • Phil Grandinetti, IIIDirector
  • K.C. KavanaghDirector
  • Steven Krause, Ph.D.Executive Officer
  • Kim WolinExecutive Officer
  • Thomas C ChestermanExecutive Officer
  • Kenneth SiegelExecutive Officer, Director
  • Jake LeachDirector
Offering amount
$10M
Amount sold
$10M
Sales commissions
$850K
Placement agents
H.C. Wainwright & Co.
First sale
Jan 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.1MraisedNov 2020 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Julie Williams, MDDirector
  • Matthew SzotDirector
  • Marc DumontDirector
  • Delphine Francois ChiavariniDirector
  • Kenneth SiegelExecutive Officer, Director
  • Thomas C ChestermanExecutive Officer
  • Jamie Bechtel, JD, Ph.D.Director
Offering amount
$3.1M
Amount sold
$3.1M
Sales commissions
$220K
Finders' fees
$29.3K
Placement agents
H.C. Wainwright & Co.
First sale
Oct 2020
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

SenesTech to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026prnewswire.com · Aug 2026

Frequently asked questions

How much funding has SenesTech raised?
SenesTech has disclosed $17.2M raised across 7 of its 10 known rounds.
Where is SenesTech headquartered?
SenesTech is headquartered in Phoenix, US.